Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Anti-CD2 MAb enters phase II for GVHD

Dec. 23, 1996

Autoimmune disease Rx enters clinical trials

Dec. 20, 1996

Antex to be issued patent covering H. influenzae proteins

Dec. 19, 1996

Positive results reported for group A Streptococcus vaccine

Dec. 18, 1996

Method of producing infectious RSV offered for licensing

Dec. 17, 1996

MedImmune files IND for HPV vaccine candidate

Dec. 16, 1996

SKB reports new vaccine compositions

Dec. 16, 1996

Affymax researches potential malaria vaccines

Dec. 16, 1996

University of Alberta discovers new chemokine-binding protein

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...